Hypertension as a risk for glioma? Evidence from a population-based study of comorbidity in glioma patients

Annals of Oncology

Volumn 15, Issue 8, 2004, Pages 1256-1260

  Houben, M P W A ^a,b   Louwman, W J ^c   Tijssen, C C ^a   Teepen, J L J M ^a   van Duijn, C M ^b   Coebergh, J W W ^b,c  

^a CPRLab   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c The Netherlands   (Netherlands)

Author keywords

Aetiology; Comorbidity; Concomitant disease; Glioma; Hypertension

Indexed keywords

ANTIHYPERTENSIVE AGENT; DIURETIC AGENT; LOOP DIURETIC AGENT; THIAZIDE DIURETIC AGENT;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER REGISTRY; CARCINOGENESIS; CASE CONTROL STUDY; CEREBROVASCULAR DISEASE; COMORBIDITY; CONFIDENCE INTERVAL; DATA ANALYSIS; FEMALE; GLIOMA; HUMAN; HYPERTENSION; HYPOTHESIS; KIDNEY CARCINOMA; MALE; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; AGE; BRAIN TUMOR; MIDDLE AGED; NETHERLANDS; REGISTER; RISK; STATISTICS;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; BRAIN NEOPLASMS; CASE-CONTROL STUDIES; COMORBIDITY; FEMALE; GLIOMA; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; NETHERLANDS; ODDS RATIO; PREVALENCE; REGISTRIES; RISK FACTORS;

EID: 4444238868     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/mdh306     Document Type: Article

References (28)

1. DeAngelis LM. Brain tumors. N Engl J Med 2001; 344: 114-123.
2. van der Sanden GAC, Schouten LJ, van Dijck JAAM et al. Incidence of primary central nervous system cancers in South and East Netherlands in 1989-1994. Neuroepidemiology 1998; 17: 247-257.
3. Louis DN, von Demiling A. Hereditary tumor syndromes of the nervous system: overview and rare syndromes. Brain Pathol 1995; 5: 145-151.
4. Osborne RH, Houben MPWA, Tijssen CC et al. The genetic epidemiology of glioma. Neurology 2001; 57: 1751-1755.
5. Ron E, Modan B, Boice JD Jr et al. Tumors of the brain and nervous system after radiotherapy in childhood. N Engl J Med 1988; 319: 1033-1039.
6. Karlsson P, Holmberg E, Lundell M et al. Intracranial tumors after exposure to ionizing radiation during infancy: a pooled analysis of two Swedish cohorts of 28,008 infants with skin hemangioma. Radiat Res 1998; 150: 357-364.
7. Wrensch M, Minn Y, Chew T et al. Epidemiology of primary brain tumors: current concepts and review of the literature. Neurooncology 2002; 4: 278-299.
8. Coebergh JWW, Janssen-Heijnen MLG, Louwman WJ, Voogd AC. Cancer Incidence, Care and Survival in the South of the Netherlands 1955-1999; A Report from the Eindhoven Cancer Registry (IKZ) with Cross-border Implications. Eindhoven: Integraal Kankercentrum Zuid (2001).
9. Coebergh JWW, Janssen-Heijnen MLG, Razenberg PP. Prevalence of co-morbidity in newly diagnosed patients with cancer: a population-based study. Crit Rev Oncol Hematol 1998; 27: 97-100.
10. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-383.
11. Coebergh JWW, Janssen-Heijnen MLG, Post PN, Razenberg PPA. Serious co-morbidity among unselected cancer patients newly diagnosed in the southeastern part of The Netherlands in 1993-1996. J Clin Epidemiol 1999; 52: 1131-1136.
12. Kleihues P, Cavenee WK. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Central Nervous System. Lyon, France: IARC Press 2000.
13. Schlehofer B, Blettner M, Preston-Martin S et al. Role of medical history in brain tumour development. Results from the international adult brain tumour study. Int J Cancer 1999; 82: 155-160.
14. Brenner AV, Linet MS, Fine HA et al. History of allergies and autoimmune diseases and risk of brain tumors in adults. Int J Cancer 2002; 99: 252-259.
15. van Rossum CTM, van de Mheen H, Witteman JCM et al. Prevalence, treatment, and control of hypertension by sociodemographic factors among the Dutch elderly. Hypertension 2000; 35: 814-821.
16. Staessen J, Bulpitt C, Clement D et al. Relation between mortality and treated blood pressure in elderly patients with hypertension: report of the European Working Party on High Blood Pressure in the Elderly. Br Med J 1989; 298: 1552-1556.
17. MRC Working Party. MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party. Br Med J (Clin Res Ed) 1985; 291: 97-104.
18. Hansson L. Treatment of hypertension in the elderly. J Hypertens Suppl 1993; 11: S25-S27.
19. Grossman E, Messerli FH, Boyko V, Goldbourt U. Is there an association between hypertension and cancer mortality? Am J Med 2002; 112: 479-486.
20. Grossman E, Messerli FH, Goldbourt U. Antihypertensive therapy and the risk of malignancies. Eur Heart J 2001; 22: 1343-1352.
21. Batty GD, Shipley MJ, Marmot MG, Davey Smith G. Blood pressure and site-specific cancer mortality: evidence from the original Whitehall study. Br J Cancer 2003; 89: 1243-1247.
22. Berleur MP, Cordier S. The role of chemical, physical, or viral exposures and health factors in neurocarcinogenesis: implications for epidemiologic studies of brain tumors. Cancer Causes Control 1995; 6: 240-256.
23. Preston-Martin S, Yu MC, Benton B, Henderson BE. N-Nitroso compounds and childhood brain tumors: a case-control study. Cancer Res 1982; 42: 5240-5245.
24. McKean-Cowdin R, Pogoda JM, Lijinsky W et al. Maternal prenatal exposure to nitrosatable drugs and childhood brain tumours. Int J Epidemiol 2003; 32: 211-217.
25. McCredie M, Maisonneuve P, Boyle P. Antenatal risk factors for malignant brain tumours in New South Wales children. Int J Cancer 1994; 56: 6-10.
26. Kuijten RR, Bunin GR, Nass CC, Meadows AT. Gestational and familial risk factors for childhood astrocytoma: results of a case-control study. Cancer Res 1990; 50: 2608-2612.
27. Ryan P, Lee MW, North B, McMichael AJ. Risk factors for tumors of the brain and meninges: results from the Adelaide Adult Brain Tumor Study. Int J Cancer 1992; 51: 20-27.
28. Mori M, Saitoh S, Takagi S et al. A review of cohort studies on the association between history of diabetes mellitus and occurrence of cancer. Asian Pac J Cancer Prev 2000; 1: 269-276.